awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47574122-2B1BF93F-818C-4AE1-A5E2-B368551A027E
Q47574122-2B1BF93F-818C-4AE1-A5E2-B368551A027E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47574122-2B1BF93F-818C-4AE1-A5E2-B368551A027E
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI.
P2860
Q47574122-2B1BF93F-818C-4AE1-A5E2-B368551A027E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47574122-2B1BF93F-818C-4AE1-A5E2-B368551A027E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a2469d2305780ee3f7f8bbbb0383571f3b4d5afe
P2860
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.